rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OVID
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Ovid Therapeutics at UBS conference: two CNS bets near key readouts
      Nov 16Investing.comOVIDUBS
      Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results
      Nov 10Yahoo FinanceOVID
      12 Health Care Stocks Moving In Monday's After-Market Session
      Nov 9BenzingaKPTIOVID
      Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue Estimates
      Nov 6Yahoo FinanceOVID
      Ovid Therapeutics to Participate in Upcoming Investor Conferences
      Nov 5Yahoo FinanceOVID
      Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Arvinas Holding Company (ARVN) and Ovid Therapeutics (OVID)

      Detailed price information for Ovid Therapeutics Inc (OVID-Q) from The Globe and Mail including charting and trades.

      Oct 9The Globe and MailARVNOVIDBHC
      Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329
      Oct 8Yahoo FinanceOVID
      Guggenheim Initiates Ovid Therapeutics at Buy
      Oct 6Yahoo FinanceOVID
      Vail Resorts, Inventiva And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
      Sep 29BenzingaIVAOVIDMTNNIO
      Ovid Therapeutics at H.C. Wainwright conference: pipeline bets gain focus
      Sep 14Investing.comOVID
      Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two

      On August 13, Ovid Therapeutics (NASDAQ:OVID) reported financial results for the second quarter ended June 30, alongside a batch of pipeline updates. The biopharmaceutical company, which focuses on treatments for brain disorders, used the update to lay out progress on two clinical programs, a leadership shakeup, and a deal that hands off one of its […]

      Sep 12Yahoo FinanceOVID
      H.C. Wainwright raises Ovid Therapeutics price target to $5 on pipeline progress
      Sep 11Investing.comOVID
      Ovid Therapeutics at cantor healthcare: kcc2 and epilepsy in focus
      Sep 10Investing.comOVID
      Ovid Therapeutics to Participate in Upcoming Investor Conferences

      NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today announced that the Company’s management will participate in two upcoming investor conferences: Cantor Global Healthcare Conference – Wednesday, September 9 at 2:10 pm ETH.C. Wainwright 28th Annual Global Investment Conference – Monday, September 14 at 11:30 am ET Webcasts of the pre

      Sep 3Yahoo FinanceOVID

      This is the newest page. Registered accounts read further back.